智能药丸市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100001238
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

[研究报告]智能药丸市场规模预计将从2021年的40.193亿美元增长到2028年的90.6129亿美元;预计 2022 年至 2028 年复合年增长率为 12.3%。

 

分析师观点

老年人口数量增加,患病率上升肥胖、胃溃疡等与生活方式相关的疾病的增加,以及癌症、糖尿病等慢性疾病的增加是支持智能药丸市场增长的一些因素。此外,不断增长的研发活动和智能药丸开发资金是推动智能药丸市场增长的主要因素之一。此外,与智能药丸相关的技术进步的兴起,例如微型相机、小型化、微处理器的可用性等,为未来的市场增长提供了利润丰厚的机会。随着痴呆症和阿尔茨海默病病例的不断增加,患者漏服药物或服用错误药物的可能性也随之增加,这增加了对智能药丸的需求和需求。因此,由于医疗保健行业的增长需求,智能药丸市场将在未来几年经历增长。

市场概览

智能药丸是胶囊大小的可摄入医疗设备,由传感器、摄像头、贴片和跟踪器等元件组成,有助于更好的诊断、患者监测以及靶向药物输送。它们主要以维生素胶囊大小的药丸形式提供,并拥有小型可穿戴传感器贴片、移动设备上的应用程序和提供商门户。这些独特的设备可以轻松吞咽,并对胃肠道 (GI) 和身体的许多其他部位进行非侵入性彻底检查。智能药丸技术帮助患者和医生跟踪他们的药物治疗方案依从性,从而提高患者的依从性。据估计,这项技术每年可为美国节省约 100 至 3000 亿美元。智能药丸市场的主要驱动力是对微创外科手术的需求不断增长以及战略合作和医疗服务的增加。智能药丸的合作伙伴关系。此外,对药物输送系统的需求不断增长也促进了智能药丸市场的增长。

战略见解

市场驱动因素

< h3>对微创外科手术的需求不断增长,推动全球智能药丸市场增长

老年人群非常容易患胃肠道疾病。目前正在评估许多智能药丸在治疗和诊断多种急性和慢性疾病方面的潜在应用。在目标部位遵循指定剂量药物的慢性病患者预计将为先进的药物输送产品形成相当大的客户群。智能药丸提供的某些好处包括先进的胶囊内窥镜检查、轻松的远程患者监控和靶向药物输送。这些因素导致越来越多地采用智能药丸来治疗胃肠道疾病或癌症患者。患者对微创治疗程序的偏好日益转变,预计将推动智能药丸市场的增长。根据 2021 年 2 月发表在 IEEE Access 上的一篇文章,微创医学已成为主流,因为它在降低术后并发症风险、减少失血量、缩短术后恢复时间以及缩小相关生理组织伤口方面具有重要的临床意义。这些因素导致越来越多地采用智能药丸来治疗胃肠道疾病或癌症患者。

对微创外科手术的需求不断增长,催生了创新技术,例如胶囊内窥镜检查。胶囊内窥镜结合混合成像技术和新组件创新,在这些疾病的早期诊断和正确治疗中发挥着至关重要的作用,并且由于其易于给药和对胃肠道进行详细观察等优势,有望取代传统内窥镜方法。道。例如,根据德克萨斯大学健康科学中心的说法,部署各种结直肠癌筛查程序(例如胶囊内窥镜检查)可以提高筛查的依从性。该大学对 50 岁至 75 岁的随机分配的患者进行了一项研究,发现胶囊内窥镜检查比 CT 结肠成像能提供更好的诊断结果。因此,这些因素可能会增加对智能药丸的需求,从而推动预测期内智能药丸市场的增长。

细分分析

根据疾病适应症,智能药丸市场分为胃肠道疾病、神经系统疾病、癌症、遗传性疾病和其他疾病适应症。 2021年,胃肠道疾病领域占据最大的市场份额。然而,预计癌症领域在预测期内的复合年增长率最高。美国疾病控制与预防中心 (CDC) 估计,每年有 60 至 7000 万美国人受到胃肠道疾病的影响,并因此而进行了数千万例内窥镜手术。还对数百万病例进行结肠镜检查以诊断或检测结直肠恶性肿瘤。患者对用于这些手术的传统硬质内窥镜感到不舒服,如果在不同的患者身上重复使用,可能会导致内部瘀伤或感染。有了智能药丸,不再需要侵入性手术:无线连接可以传输实时数据,电池技术和板载内存的发展使其可以在体内进行长期传感。

智能药丸已经改变了胃肠道疾病的诊断,它们可能很快就能取代内窥镜检查等传统诊断方法。在传统手术中,将内窥镜探头放入患者的食道,然后放入上胃肠道和下胃肠道,以进行诊断。食道内壁有穿孔或撕裂的危险,患者在治疗期间和治疗后会感到不适。然而,智能药丸或无线胶囊内窥镜 (WCE) 可以被食用并进行操作,以获取图像,而患者只需最少的准备(例如镇静)。内置传感器使医生能够测量肠道中的所有液体和气体,为医生提供人体的多维图像。因此,上述因素支撑了智能药丸市场细分市场的增长。

区域分析

亚太智能药丸市场受到重视2021年为4.8875亿美元,预计到2028年将达到11.5622亿美元;预计在预测期内复合年增长率为 13.1%。亚太地区智能药丸市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。 2021 年,日本在亚太地区智能药丸市场中占据最大份额。该国智能药丸市场的增长主要受到大规模发展和财政援助的推动,加速了该国智能药丸的采用和接受。神经系统疾病的日益流行可能需要智能药丸技术。例如,据厚生劳动省称,2018年,约有460万人患有某种形式的痴呆症,预计到2025年,总人数将飙升至约730万人,即占日本65岁或以上人口的五分之一。此外,日本胃肠道疾病的日益流行也推动了对智能药丸的需求。根据研究“日本胃肠道疾病趋势”,包括日本在内的东亚国家胃癌发病率较高。报告还报道,胃食管反流病(GERD)和炎症性肠病(IBD)的发病率不断增加。

科学家和研究人员也帮助生物技术和生命科学市场增长。日本学术振兴会 (JSPS) 估计将有近 2.7 亿美元(300 亿日元)的资金用于提供研究资助,这将进一步促进研究人员对新技术的开发。因此,工厂的建立和有利的资金&赠款将支持预测期内智能药丸市场的增长。

主要参与者分析

智能药丸市场分析包括以下参与者: CapsoVision 公司;美敦力;检查帽;宾得医疗;奥林巴斯公司;身体帽;大冢美国制药公司; IntroMedic有限公司;金山科技技术。;在智能药丸市场的参与者中,美敦力(Medtronic)和 CapsoVision, Inc 凭借多元化的产品组合位居前两位。

最新动态

智能药丸市场的公司高度采用并购等无机和有机策略。下面列出了最近的一些关键市场动态:

  • 2022 年 1 月,诺和诺德印度公司推出了一种抗糖尿病药物的口服制剂,仅以注射剂形式提供。该公司声称,这种新药有助于更好地控制成人 2 型糖尿病患者的血糖水平和体重。凭借这一突破,该公司获得了 2020 年 Prix Galien 奖,这是业内享有盛誉的奖项。该药物于 2020 年获得印度药品监管局批准。
  • 2020 年 12 月,CapsoVision, Inc. 获得了国际标准组织 (ISO) 27001 安全认证。认证范围包括CapsoVision总部和该公司的CapsoCloud软件。
  • 2020年8月,大冢美国制药公司宣布收购Proteus Digital Health, Inc.(Proteus)的资产,包括其可摄入和可穿戴传感器技术的资产和知识产权。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in market the smart pills market?

The smart pills market majorly consists of the players such as CapsoVision, Inc.; Medtronic.; Check-Cap; PENTAX Medical; Olympus Corporation; BodyCap.; Otsuka America Pharmaceutical, Inc.; IntroMedic; Jinshan Science & Technology (Group) Co., Ltd.; and RF Co., Ltd.

What is the smart pills market?

Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of a vitamin capsule sized pill and possess small wearable sensor patch, an application on a mobile device, and a provider portal.

What are the driving factors for the smart pills market across the country?

The factors that are driving and restraining factors that will affect the smart pills market in the coming years. Factors such as the increase in the demand for minimally invasive devices in the US, and the rise in the gastrointestinal disorders in U.S. characterize the growth in North America. In addition, rapid technological advancements in drug delivery are likely to boost the market for smart pills.

Which segment is dominating the smart pills market?

The global smart pills market based on application, is segmented into capsule endoscopy, drug delivery, and patient monitoring. In 2021, capsule endoscopy segment held largest market share. However, drug delivery is estimated to grow at the fastest CAGR of 13.4% during the forecast period.

The List of Companies - Smart Pills Market

  1. CapsoVision, Inc.
  2. Given Imaging, Inc.
  3. Check-Cap
  4. PENTAX Medical
  5. Olympus
  6. BodyCap
  7. Otsuka America Pharmaceutical, Inc.
  8. IntroMedic
  9. Jinshan Science & Technology (Group) Co., Ltd.
  10. RF Co., Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports